Reinvigorated global efforts needed to curb rising malaria threat
On Dec. 11, 2024, the World Health Organization (WHO) reported new data has revealed that an estimated 2.2…
Biotechnology | HIV | Infectious Disease | Life Science News | Medicine | Vaccine | WHO
WHO study lists top endemic pathogens for which new vaccines are urgently needed
On Nov. 5, 2024, a World Health Organization (WHO) study published in eBioMedicine named 17 pathogens that regularly…
Biotechnology | Dentistry | Diagnostics | Disease | Life Science News | Medicine | Orthopedic | Therapeutics
Rochester-based Saunders Foundation makes $30 million commitment to the University of Rochester Medical Center
On Oct. 23, 2024, the University of Rochester announced that the Saunders Foundation, led by University Trustee Emeritus…
Hospital price increases since 2000 outpaced inflation by more than double, Baker Institute reported
On Oct. 21, 2024, Rice University’s Baker Institute for Public Policy reported that hospital service prices surged more…
Biotechnology | Diagnostics | Disease | Life Science News | Medicine | Non-Profit Research | Pharmaceutical | Therapeutics
Sanofi commits $18 million to Howard University College of Medicine, Meharry Medical College, and Morehouse School of Medicine to increase diversity in clinical studies
On Oct. 16, 2024, Sanofi announced it will contribute $18 million to three Historically Black Medical Schools to…
Biotechnology | Diagnostics | Infectious Disease | Life Science News | Medicine | Therapeutics | WHO
WHO reported Increase in Rwanda Marburg virus disease incidence
On Oct. 11, 2024, the World Health Organization (WHO) reported that a total of 58 cases of Marburg…
Artificial Intelligence | Biotechnology | Chemical | Genomics | Life Science News | Medicine | Non-Profit Research | Therapeutics
Nobel Prize in Chemistry awarded to David Baker “for computational protein design”; Demis Hassabis and John M. Jumper “for protein structure prediction”
On Oct. 9, 2024, the Nobel Foundation awarded the Nobel Prize in Chemistry: one half to David Baker,…
Nobel Prize in Physiology or Medicine awarded to Victor Ambros and Gary Ruvkun
On Oct. 7, 2024, The Nobel Foundation announced that Victor Ambros from Harvard University and Gary Ruvkun from…
Biotechnology | Diagnostics | Infectious Disease | Life Science News | Medicine | Therapeutics | Vaccine | WHO
WHO launches global strategic plan to fight rising dengue and other Aedes-borne arboviral diseases
On Oct. 3, 2024,the World Health Organization (WHO) launched the Global Strategic Preparedness, Readiness and Response Plan (SPRP)…
Biotechnology | Chemical | Diagnostics | Environmental | Life Science News | Medicine | Non-Profit Research | Therapeutics
New data science tool significantly increased molecular analysis of our environment
On Sept. 20, 2024, a research team led by scientists at the University of California, Riverside, announced they…
Biotechnology | Diagnostics | Infectious Disease | Life Science News | Medicine | Non-Profit Research | Therapeutics | Vaccine
new data showed Over half of U.S. kids infected with RSV in infancy
On Sept. 19, 2024, a U.S. population-based birth cohort study was released that showed that 53.4% of babies…
Biotechnology | Infectious Disease | Life Science News | Medicine | Non-Profit Research | Rare Disease | Therapeutics | WHO | Women's Health
WHO verified Jordan as first country to eliminate leprosy
On Sept. 19, 2024, the World Health Organization (WHO) announced that Jordan had become the first country in…
Biology | Biotechnology | Diagnostics | Disease | Life Science News | Medicine | Neurology | Non-Profit Research | Therapeutics
landmark UT Health San Antonio study found genetic risk-factor overlap between Alzheimer’s disease, and dementias
On Sept. 17, 2024, in landmark research, scientists at The University of Texas Health Science Center at San…
Drug Resistant Bacteria projected to Kill Tens of Millions by 2050
On Sept. 16, 2024, a study by the Global Research on Antimicrobial Resistance (GRAM) Project reported that antimicrobial…
Biology | Biotechnology | CRO | Diagnostics | Life Science News | Medicine | Therapeutics
TGen launched Center for Spatial Multi-Omics dedicated to transforming biomedical research through spatial biology
On Sep. 11, 2024, the Translational Genomics Research Institute (TGen), part of City of Hope, announced the launch…
Biotechnology | COVID-19 | Life Science News | Medical Device | Medicine | Pharmaceutical | Therapeutics | Vaccine
Covid-19 pandemic changed scientific publishing
On Sep. 9, 2024, Santo Fortunato, a professor at Luddy School of Informatics, reported that an international research…
Biotechnology | Disease | Life Science News | Medicine | Vaccine | WHO
Outbreak of Oropouche virus disease reported in South America
On Aug. 23, 2024, the World Health Organization (WHO) reported an outbreak of Oropouche virus (OROV) in the…
Western university announced newly discovered protein stops dNA damage
On Aug. 15, 2024, researcher from from Western University announced they had discovered a protein that has the…
Biotechnology | Disease | Life Science News | Medicine | Vaccine | WHO
WHO declared mpox outbreak a public health emergency of international concern
On Aug. 14, 2024, The World Health Organization declared that the upsurge of mpox in the Democratic Republic…
Artificial Intelligence | Biotechnology | CRISPR | Genomics | Life Science History | Life Science News | Medicine | NIH | Non-Profit Research | Therapeutics | Vaccine
Biden announced $150 million in research grants as part of his ‘moonshot’ push to fight cancer
On Aug. 13, 2024, President Joe Biden announced $150 million in awards from the Advanced Research Projects Agency…
Artificial Intelligence | Biotechnology | Diagnostics | Life Science News | Medicine | Non-Profit Research | Therapeutics
HHMI Invested $500 Million in AI-Driven Life Sciences Research
On Aug. 12, 2024, The Howard Hughes Medical Institute (HHMI) announced AI@HHMI, a $500 million investment over the…
When it comes to DNA replication, humans and baker’s yeast are more alike than different
On Aug. 1, 2024, the Van Andel Institute reported that humans and baker’s yeast have more in common…
Biotechnology | Diagnostics | Disease | Life Science News | Medicine | Oncology | Therapeutics | Women's Health
Generation X and Millennials in U.S. Have Higher Risk of Developing 17 Cancers Compared to Older Generations
On Jul. 31, 2024, a large study led by researchers at the American Cancer Society (ACS) suggested incidence…
Study shows tiny animals steal antibiotic recipes from bacteria
On Jul. 19, 2024, a study led by the University of Oxford reported that a group of small…
Thanks to Bloomberg Philanthropies $1 billion gift, most Johns Hopkins medical students no longer pay tuition
On Jul. 8, 2024, Bloomberg Philanthropies announced that thanks to a $1 billion gift medical students at Johns…
Dupixent® (dupilumab) Approved in the European Union as the First-ever Targeted Therapy for Patients with COPD
On Jul. 3, 2024, Regeneron Pharmaceuticals and Sanofi announced that the European Commission (EC) has approved Dupixent® (dupilumab)…
Biotechnology | Disease | FDA | Life Science News | Medicine | Therapeutics
FDA Expanded Approval of Gene Therapy for Patients with Duchenne Muscular Dystrophy
On Jun. 20, 2024, the U.S. Food and Drug Administration expanded the approval of Sarepta Therapeutics’ Elevidys (delandistrogene…
NIH launched $30 million pilot to test feasibility of a national primary care research network
On Jun. 6, 2024, the National Institutes of Health (NIH) announced it was investing approximately $30 million in…
Biotechnology | Diagnostics | Infectious Disease | Life Science News | Medicine | Neurology | Non-Profit Research | Oncology | Therapeutics
CIRM awarded $53 million to clinical research in heart failure and cystic fibrosis, supporting 10 translational projects
On May 30, 2024, the California Institute for Regenerative Medicine (CIRM) announced it had awarded $53 million to…
Biogen received European Commission approval for QALSODY® (tofersen), first therapy for rare, genetic form of ALS
On May 30, 2024, Biogen announced that the European Commission (EC) had granted marketing authorization under exceptional circumstances…